Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (29408)	11/18/1999 8:31:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 32384

Ligand Plans to Commence Exchange Offer for Certain Warrants SAN DIEGO--(BUSINESS WIRE)--Nov. 18, 1999--Ligand Pharmaceuticals Incorporated (Nasdaq:LGND - news) announced today its plans to commence an offer to exchange warrants (Nasdaq:LGNDW - news) to purchase shares of Ligand common stock and cash payments of $7.12 per warrant (representing the exercise price for such warrants) for shares of Ligand common stock and $1.12 per warrant. The offer will expire at 5:00 p.m. New York City time on December 17, 1999, unless the offer is extended.